A Unified Framework for Alzheimer’s Disease Knowledge Graphs: Architectures, Principles, and Clinical Translation
Open Access
- 19 May 2025
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 15 (5) , 523
Abstract
This review paper synthesizes the application of knowledge graphs (KGs) in Alzheimer’s disease (AD) research, based on two basic questions, as follows: what types of input data are available to construct these knowledge graphs, and what purpose the knowledge graph is intended to fulfill. We synthesize results from existing works to illustrate how diverse knowledge graph structures behave in different data availability settings with distinct application targets in AD research. By comparative analysis, we define the best methodology practices by data type (literature, structured databases, neuroimaging, and clinical records) and application of interest (drug repurposing, disease classification, mechanism discovery, and clinical decision support). From this analysis, we recommend AD-KG 2.0, which is a new framework that coalesces best practices into a unifying architecture with well-defined decision pathways for implementation. Our key contributions are as follows: (1) a dynamic adaptation mechanism that adapts methodological elements automatically according to both data availability and application objectives, (2) a specialized semantic alignment layer that harmonizes terminologies across biological scales, and (3) a multi-constraint optimization approach for knowledge graph building. The framework accommodates a variety of applications, including drug repurposing, patient stratification for precision medicine, disease progression modeling, and clinical decision support. Our system, with a decision tree structured and pipeline layered architecture, offers research precise directions on how to use knowledge graphs in AD research by aligning methodological choice decisions with respective data availability and application goals. We provide precise component designs and adaptation processes that deliver optimal performance across varying research and clinical settings. We conclude by addressing implementation challenges and future directions for translating knowledge graph technologies from research tool to clinical use, with a specific focus on interpretability, workflow integration, and regulatory matters.Keywords
Funding Information
- European Union (101159214)
This publication has 41 references indexed in Scilit:
- Alzheimer's disease knowledge graph enhances knowledge discovery and disease predictionComputers in Biology and Medicine, 2025
- Graph embedding-based link prediction for literature-based discovery in Alzheimer’s DiseaseJournal of Biomedical Informatics, 2023
- Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: A use case studying depression as a risk factor for Alzheimer’s diseaseJournal of Biomedical Informatics, 2023
- Multi-relation graph convolutional network for Alzheimer’s disease diagnosis using structural MRIKnowledge-Based Systems, 2023
- Deep learning-based EEG analysis to classify normal, mild cognitive impairment, and dementia: Algorithms and datasetNeuroImage, 2023
- On the limits of graph neural networks for the early diagnosis of Alzheimer’s diseaseScientific Reports, 2022
- KG-DTI: a knowledge graph based deep learning method for drug-target interaction predictions and Alzheimer’s disease drug repositionsApplied Intelligence, 2021
- BioBERT: a pre-trained biomedical language representation model for biomedical text miningBioinformatics, 2019
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasetsNucleic Acids Research, 2018
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011